Hope for Alzheimer`s patients? Dipeptide blocks the formation of toxic amyloid β-peptide aggregates in mice

(PhysOrg.com) -- Alzheimer's disease is the primary cause of age-related dementia. About 15 million people are affected by this neurodegenerative disease worldwide. It has so far not been possible to combat the causes of Alzheimer`s disease. Israeli researchers have now developed a novel approach for treatment. As they report in the journal Angewandte Chemie, the new drug, a molecule made from two nonphysiological amino acids, improves the cognitive abilities of mice with Alzheimer`s and reduces the amyloid plaques in their brains.

Read the whole article on Physorg

More from Physorg